Envestnet Asset Management
NXTM

Envestnet Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Envestnet Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12
Closed – – 3027
2017
Q4 		$0 Sell
12
-9
-43% -$237 ﹤0.01% 3043
2017
Q3 		$1K Sell
21
-1,913
-99% -$51K ﹤0.01% 2888
2017
Q2 		$48K Buy
1,934
+367
+23% +$9.09K ﹤0.01% 2374
2017
Q1 		$42K Buy
+1,567
New +$43.3K ﹤0.01% 2474

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Envestnet Asset Management's NXTM Position: Q1 2018 in Review

Envestnet Asset Management sold out of NxStage Medical Inc. (NXTM) in Q1 2018, closing a stake of 12 shares.

Envestnet Asset Management first reported a position in NXTM in Q1 2017 and held it in 4 quarters. The position peaked at $48K in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

  • Envestnet Asset Management reported no remaining NxStage Medical Inc. position as of Q1 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 12 NxStage Medical Inc. shares in Q1 2018.
  • Envestnet Asset Management first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 4 quarters.
  • Envestnet Asset Management's NxStage Medical Inc. position peaked at $48K in Q2 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on Envestnet Asset Management's 13F filing for Q1 2018, filed 9 May 2018.